MARKET

RNAZ

RNAZ

Transcode Therapeutics Inc
NASDAQ
9.07
-0.44
-4.63%
After Hours: 8.85 -0.22 -2.40% 17:26 12/15 EST
OPEN
9.56
PREV CLOSE
9.51
HIGH
9.58
LOW
8.69
VOLUME
8.90K
TURNOVER
--
52 WEEK HIGH
468.44
52 WEEK LOW
6.15
MARKET CAP
8.32M
P/E (TTM)
-0.0256
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RNAZ last week (1208-1212)?
Weekly Report · 13h ago
TransCode Therapeutics Files For $150M Mixed Shelf Offering
Benzinga · 3d ago
TRANSCODE THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $150 MLN – SEC FILING
Reuters · 3d ago
TransCode's TTX-MC138 To Enter Phase 2a Trial As Part Of Quantum Leap PRE-I-SPY Platform
NASDAQ · 3d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 4d ago
TransCode Announces Collaboration for Phase 2a Trial
TipRanks · 4d ago
Transcode, Quantum Leap announce new collaboration to study TTX-MC138
TipRanks · 4d ago
TransCode Therapeutics and Quantum Leap Launch Phase 2a Trial for TTX-MC138 in Colorectal Cancer
Reuters · 4d ago
More
About RNAZ
TransCode Therapeutics, Inc. is a clinical-stage oncology company focused on treating metastatic disease. It is defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. Its lead candidate, TTX-MC138, targets metastatic tumors overexpressing microRNA-10b, a biomarker of metastasis. The Company is also developing a portfolio of RNA therapeutic candidates to overcome delivery challenges and unlock access to novel genetic targets. Its preclinical programs include TTX-siPDL1 (siRNA modulator of PD-L1), TTX-RIGA (RNA agonist of RIG-I for innate immunity activation), and TTX-siMYC (siRNA inhibitor of c-MYC). Additionally, R&D efforts are exploring the combination of TTX-MC138 and seviprotimut-L technologies to enhance therapeutic impact.

Webull offers Transcode Therapeutics Inc stock information, including NASDAQ: RNAZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RNAZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RNAZ stock methods without spending real money on the virtual paper trading platform.